Welcome to the Integrated System for Pfizer Investigator Initiated Research (INSPIIRE)


For security, please type the letters above:
  New Users
Please email us at: CTD@pfizer.com for assistance with the CLINICAL TRIAL DATA REQUESTS
Please email us at: IIR@pfizer.com for assistance with INVESTIGATOR INITIATED RESEARCH or COMPOUND TRANSFER REQUESTS
ATTENTION HIV/Maraviroc Requests: Please contact viiv.csgoperations@viivhealthcare.com
Site is NOT compatible with Safari. Please use IE or Chrome when using this site.
NOTE: As of 03-Sept-2015, Pfizer has acquired Hospira. We will not accept any new proposals for legacy Hospira products until 01-Mar-2016.
UPDATE: The INSPIIRE portal will be offline from 12:00pm EST March 18 through March 20. The portal will back up on March 21, 9am EST.
The deadline for the 2016 ASPIRE Rheumatology, Dermatology and IBD Program, has been extended to March 17.